throbber
Page 1
`
`RB Ex. 2024
`BDSI v. RB PHARMACEUTICALS LTD
`IPR2014-00325
`
`

`
`.r'ir'r}u.='si{i.'2.-H .“‘,'.'J.'.='.'.rn': l);wid 15. Troy
`.”mrh.u:.£ Mm1.r:grr:'.' M;m I-I;11l})c1'
`M(.L1':'m'.i Hg Mrumgr.-1‘: AI liwn I’: well
`f)er.s'ig:rm': Dong Srnmrk
`(.'rJm.}'Jr;.\':'£rA:'.' 1\=Z;nyl21I1({ (JmI1pn.~siI.im1 In(?./:'\SI
`I"-‘nunh Edition
`
`(J(;py1‘ig'}I|. G‘) 20 ll [.ippim:u1'1 W'il1i2I|nH &: Wilkim, 2| W(J|L(!I'5 Klllwcr |}|1sim-as
`3:3] WcsL(.}a11I1dL*1I SI]'{:t’.l
`:';?§UW;1l11ltl Slrcet
`
`[’>;1|tim<.}|'t:, Ml") 2|2Ul
`Prinlctl in(I|1i11n
`
`Pllilatlclpllizt, PA |‘.}l(l[i
`
`All rigl1l.‘s 1'esc1w:({. This Imuk is |)I‘Ult..’('l('(| by ct>py|‘ig}|I. No pnrl of this lmnk may he l't’|}I'{}(ll1(‘t.'l.l or
`lI'ElIl.*iIl1i|lt..’(| in any fnrm or by any rm.-m1_~s. im:ln(liI1g;1s p}1(>l<1(‘<Jpi('.‘a' ()I'.\'("¢lllIl(:(1-ill or (Jl}I(.‘l' (’|{_'.L‘l['(J{Ii('
`L'(J[)i{_'..‘i,
`(Z-I‘ tllilimrtl by any i1'If()I'I1I;1Ii0II slnlzlgtr and I'{.'II'i<:v'.ll sysltrlll willmut Wl‘i[[(.'I1 |)(’I'lIIi5.\'i()II |‘I‘mn
`Ihe trupyriglll owlurt‘. L-.x(‘t-pi [hr Init-i't|lIUIuli{)|1s I-.'|n|}0(1i(.-(I in cI'iti(:;1I ;l1'Ii(‘.ltts:1I1d r(.-\Iit'wx. M2IIc1'i21Is
`;1pp(.=21I‘iI)g,' in l|1iS Imnk pI‘cp21I‘:-.(1 by intiividlials 21>; purl nf'[I'1(:i1‘nf'li{'iz1| (l|.Ili{;'.‘i as U.3‘i. g:>\'t'I'nIn('1Il cm-
`|}|())’{'.t'.\'
`‘.1I‘('. nut c<}\'('I'r:(l by the ::lJ(.w'('—IIu’Illimnrrl cup)-'I'i;_>_'hl, To |'{.'(|l.l('.*5l pLtI'111i.\'siuI1,
`|)|t-ast-r (:oIn;1('I
`ljppincznll Wi||i:a.n1_~; & Wilkins at. :";:$[) Walnut St1'c{.-t.,
`l’|1il;1(l(:1pl1i;1, ]’r'\
`IEIIUG, vial ca-nlzlil at [J¢:I'lIli.‘i-
`sitJuss@lww,L'n|1I, mw-'i;1 wt-bsilc ell |WW.(.'()l]l
`(pI'0(1lI(‘.T..‘i and .'iI‘.?l'\'i(‘<_'.‘i).
`9875:")-'}§‘}‘2|
`
`l.i|J1':1I‘y of (‘.mI,:_=;1'css ( IzllnlngiIn_{—in—P11bli(':11im1 l)21Id
`
`Rnwluntl. Mu]('{}|n1.
`
`|)|lélI'I‘Il1l{I()(lyI1}\I‘I1i(:N
`(.'l1niL'21] piI;u'1n:1(:nkim:li(:s unrl
`Ruwlzmd and ‘]‘ht>1I:21.~; N. ‘l'm‘.cI'. —4lI|I «(L
`p. ; cm.
`
`|{t;‘\-'. <.-(L nl': (lliniczll p}::n'n::1('nkim-Ii<:r;.
`ISBN ‘J78-I}-7817-:')f)1’}9-7
`
`|E}‘.}:'1,
`
`(:0m:<-p1.~; and li]J|}|i(.'2lli(>ll$ /'
`
`l\/lalrnlm
`
`1. l’|umn2u:,'nkin(:liL's. 2. (Jln-.'II1<1Il1t.r1';1p}'. 1. TU'I‘.('?l‘, 'l'hnIn21s N. [I. Run-'|;n1(1, I.\eI;11(:(:|m. (llinicztl plmrv
`ITl‘.l{I(lkil1(?Ii(‘.\i. II]. Tiilc.
`
`I. Pl1ElI‘I'li|i1.('l>kilI(.'Ii(IS. 2.
`[])NI.M:
`RM3{)I .:').Rf5H ‘J.l'J[)9
`['il:'"1’.7—cic‘2‘2
`
`l'):'l1g'I'1nr1‘21py. QV 38 R88.‘-’:(‘ QUUEIJ
`
`2(}l']UU28‘})28
`
`l)]S(.'l..«’\lJ\rIl'IR
`
`(hm: |1;lsi)L-L-.11 lilktrn In (‘<)nli1'|n the11(:t‘1II'a(1ynf'l}1(‘iI1lm'nI2lIi(nI [)l'(f.‘1'I.‘lII and In (It-s('I'il)(r ;_=;(.-nt..-I'-
`:1I|y;I(.'('('pI(.'(l ])i’Elt.‘.Ii(I{'.S. lltawwc-1', Ilnr 2uIII101's, L'(1iIUl'.‘s'. and ]J11h|i.~;}urI';11‘(r Ilnl l'('.S'p(:-l|.‘ii}Jl{.' for ¢::‘|'m:~;
`U1" i}I}"|i.'i.\'i(}ll.*i 01' for any (‘(11:51-.q1IcI1('(m f'1'<Jn1 ztpplimtinra :;l'1hc iIIl':>r1n:1I1tn| in (Ills hunk and 1n:tkI.'
`nu wm'J‘;I!II_v. cxpI'(ts.w<| 01' ilnplit-.d, with I'{_‘.‘i}J{_‘(."[ In the t‘lI|‘I't-11(‘y, (‘fJII]|)|{?l(‘lIt'.SS, 01'
`:iI‘.‘{’llI".ll.'}' of [In-
`¢.'U1]|(?nI5 n['[l1c pnbl1'(:'<l1in1|.
`.-'\ppIiL".lIiU1I of [his i11lin'IrI;1lit)II in 21 ]Jl1l'[i(‘l.I|ElI'Villlzliitlll
`I'{"Ii12iilIS I|1<-
`|l|'E>|i’.*i&iuIl;l] :'(r.~e|m11.~;i|1ilil}-' of the pr:u'1it.i<mcr; the (‘|i|1i-ca] t1'(.'21n11(':It.~; (lc.x'n'il)c:| and :'cL:un'1|n('I1d(.-tl
`1112!)’ nnl |}(‘ {‘(JI!N'i(I(.'I'(?-fl ei})xn111l(% '.ln(|
`t1ni\«'(rI‘H;Il rec:J1I11I1cIIt.l2uitms.
`
`|121Vc{:x(:I'It.'(1 L:vcry {=.f'i'U1'i to C1I.*ilIl'(‘ Ih21l(1I‘ng .*it:|(.'('Ii(JI1 and
`‘[‘}:(r:1l1I.|mI's. (3(“I{)l'S,1Ill(| pu|)1is|1(.-1'
`(ltJs21;_§<~.~icI fbrlll in l}Ii.~' Itxl ':II'(.' in :1('{:<JI'(InII(:c with the (iL1I‘|‘t‘I][
`l'(_’(‘.(JI1'IIIl(“l'l(|1l|innsand [)I';1(‘Iit'(3 al
`I|n- Iimv0I'p11h|it.‘el1it>1I. H{}W(.'\’L'l', in \-'i(.‘W nI'n|1g0in;_;' rcsc:11'(:|1. (.'h'.mgL's in g'(1\-'e|':I1I1t:1II I‘cgu|2ltit>n_~;,
`and |'.|1(' {:<)nsI'.1I1l Ilnw 0i'iI1l'tJ1'|1I;1lin|I rclutillg to (II'1I;;'
`l|1(.'r2I[)}-' and (II'I.Ig' rL-:u‘timI.-s, the :‘(%;1(l('£'
`is
`u:'g(:d In (‘h(’('k Iht' p2u‘.k;1gL'
`iIlS{.'l'1 I'm‘ (‘:1(:]1 (lI‘L1gf'uI'2u1y (‘I1;1|1;.§0 in indi(';1Ii(m5 and r.|<}s:1g_{t.* and lin‘
`:1.(I(It.-(I w;1I'IIiI1gs and |}l'[:(‘i1l1Ei()l1.*i. This is [)21I'ti(‘.L11;1|‘1)' in1pnrI;nn when Lin: I1-.(‘.o|IIII|t=.|n|{*.rl agent is 2:
`nvw 01' i1If'I'1'qtIL'J:l|y (.'lIll)|{)y('{| (l1'I1g.
`Ilzwv [“¢m(l and Drug
`|)lI|J1iCE1li(JI1
`in [his
`.‘SOIm-
`tl1'1Igs dntl
`Inc(.|i::21|
`dc.-\riL'L-5 p|'(:s;(r|m.-(I
`:'\{ln!iI1is'{l'}|li{)I] (FDA) ['|('.'Ell‘dl](.‘(‘ Ih1'li11:iIctl lm‘ in mslricu-(l 1-¢_-s¢_-;11-cl; _-;¢_=1|ing_~;_ ][ ‘:5 [hp rq-,~;pr)|1.~ibi1—
`ily uI' IIn- In-ullll (_".1I‘{' }JI'n\*it1(?1' I0 :d.~;(':'I'l2liI: Iht‘ i"l);'\ .\'l'.1ll1S of‘:-zlrh (l1'ug¢;|' (-{(3-'i[.'{' plnllined Ihr wt‘
`in lhcirc]inir;1] [):'2u'Iiu:_
`
`To |)lII'(‘}lE1S('1|-{|(|itirJI1iI| (.‘()pit'.‘iI‘)['Il1ir4I>00k.(‘E1“ <mI't‘1Islmm.-rser\-icc-rlcpummrnt an (800) (i3H—f-9f}3()
`OI‘ fax 0r(1(‘rs Ln (.‘-fill) ‘.Z2.‘-5-2.‘-’:2{}, [1I1(’I‘t1nIim12Il ('1IslmI1('1's fihtlllltl ml] {3(J|) ‘£23—2f’;UU.
`
`‘H1/'.v'a"J'u'.=J..\' rm H3." hH..r'.>‘.='m': }IT.Tpi//\\'\\'W.]W\1'.{‘(JI'll. ljppirnintt W i||i;m1s 8: Wilkins
`1I'.r's'f! I,fjJf)f;:r'r;f( 1*1".¢':’:'.':}.r.rr.=\' L‘.-I’
`(—H_.“mm,.- _.,-(_.n,i(-(-
`|'(_'])l'(.'S{‘l1l1lli\’(T5 21:1’ ;1\*;1i|'.l|Jlc I'I'mn 8:30 illll In (3:00 pm. F.ST.
`
`Page 2
`
`CCS1209
`
`Page 2
`
`

`
`CHAPTER
`
`Therapeutic Relevance
`
`CLINICAL SETTING
`
`'l‘|'1t):se pzttienls who stiller ['t‘t)m ehrtmit: ailments stteh as (lii1l)(’L(‘5'(lll(l e]Jile])st}-' 11121}-' have
`lo take (lrttgs tavezy (lay lot‘ the rest 01' their live:-2. Al the. ntltert.-xtt'e.111e are tlmsae who tttke
`at single dose nf';t tltwtg to relieve an <.)t'e;tsit)1t;tl l‘I{'EltlElt.‘l'I(.'. The tlurtttitm ulitlrttg tl1et‘;tpy
`is ttstutlly hetwetzn these exttetttes. The mnnttet‘ in whieh ':1(ll'tlg is taken is ('2lllt.'(l zt dosage
`regimen. Both the (lllI"cH_it)I] n['t.lt‘ttg l|t<-'1‘;tp}-' and the <l<as;tgt- t‘egimett tlepetttl ()1! the ther-
`El]J(.'UIl(‘ t.Jh_]e(:1ive, whitth nut}-' he tlte ettre. the I1ti1ig:tt'itatt, tn‘ the [)l'(‘.\’['illIl()ll t}['tli.~;e.:t:at* or
`etmclitimt.~t su['I'e1‘e(l by ])t11ient.~t.
`l5(‘.(‘E1tIH(? all (lrttg‘.<t exhihit smne ll|l(l(‘Hl]‘1ll)lt'3 t.'llt‘{.‘l.‘-%, h‘tlt.‘lI
`213-; clruwsi11e:~ts, (ll‘)J'lIt'.?:s'5 of the tttmtlh, }_§:t.~'.1mintestitt;1I it‘t‘it2tIim1, t1ttLtse2t.;tt't<l |typ<)ten.~timt,
`attttteestsfttl tirttg tltt-.t';1p)* is 2t(:|1ieve(i I:-y ttptitttztlly l):1lmtt'ittg the (lt'Hit'2t|)|t.- ‘dl'tLl the '.llI(l('..H'll‘—
`able efl'ee1<;. Tu :1(‘.i1l{':\’t‘." uptitnal tlterttpy. the ll])].)]'()pl‘ii1I{? "(I1'1t;_=_' of eltoiet--" must lirst he
`stelttctt-.-(1. 'I:his (l(f(‘.l!s‘l()l1 implies ill] 2tt:t‘ttt':1te ciiztgttusir-; ulitlte (li.~te;1.~'e or ('(}ll(lllit)n, 11 knowl-
`etlgre of the ttlittieul state ttlithe pdllt-‘I'1t,'¢1I‘t(l ;1.~;t)ttn(l 1tt1<let'5tett1dittg' -:)|' the ])i'l21I‘l‘ll1l(‘t)li1{‘I'—
`apet1t.i(‘ I1'1;11t:tg_r_'ert1ettt of the (ll:-%C2lSt:.'. Then the qttestimtrt til", Itow t1tut'h? lt0\-\-' olten? and
`how inttg‘? must he ;1I]SW('I‘()(l.
`'I‘i1eqt1t:stit>n, him much? [‘t;‘.('{}gI‘tlY.tLZ.\‘- that the t1t;tg_=_'t'tittttie.~t n|' the ther:tpeI.tti(' ;tn(l;1<i—
`\’t’l‘St;E I‘{?S[J0ll.*§{:S are ftttttitintts of the size ttlklttst: given. 'l'n |)2tt';tpht‘;tse the ]tith—t'ettlttt)-'
`physicitttt Pztrttcel.-ttt.a, "nil drttgs ;1:‘t--
`])(li.‘«3{JI1S.
`it isjttst :1 mullet‘ of tltaste." hut‘ example.
`23') mg tJi';1spi1‘it1 (_l0e.~: little to ztlievittte 21 Iteadztttltez :1 (lo.-te Cl{l.*i{‘l‘ to .‘-ltltl in ($00 tug is
`Iteetletl. with ]it.t.le ill e['|‘eet.
`|I(>we.ve.t‘, 10 3; taken all at ()I1(‘.('.
`(2211) he ilttttl,
`ttscpt-'('i‘.tlh-' in
`ymmg t‘.hiit,lt'eI1.’l'l1e t]lI(?Hll{)l1, how often? t‘et:ttgtti?.es Ilte lII1I}()I‘lill‘1(‘.t.‘ of time. in that t.I1e
`|1l:lgllll.U(lt'.: n['the effet‘t eventttztlly tleelitttts with titne Ittllntvittg 11 single (inst-‘ t>I'tlI'ttg. 'l'|te
`([1l(3.‘x'llfJl'l,l'1t)Wl(}I]g?l‘C(Tt}}_{I)lZtEH that statue t‘.0t1tlitinn.~t are til" limited tlttrutiutt, t-\'|ti1e;1t‘0.~:t
`(in t_et'ms 0[':~'i(le e.['l"et‘ts. l.()Klt'll)', eemmn1it'..~s) is int‘t1t'reti with (.‘(}1‘Illltll()'|.IH (lt'tI§.;' El(lI]lliliH—
`1:';11i()|1. In [)l‘}ltIllt.'t:_ tltcse qttestlitatts etttttmt he t'<m1pIete|y tlivttttetl limtn one 2ll1tJlll(‘l'.
`I,-0]. (_xm“P]{.3, 1|-,1; (‘t}tl\’()lllt.:ltt‘.(: ttlgix-'ittg t1 l;1t'gt‘t'
`(lt).‘.«'t;'. less lteqttetttly may he llttll‘-1‘ than
`()l'iSet hy an lIl(ZI‘{?El5t‘.(l ineitlenee tJ[' t0xieit.,\-'.
`iI.~' tttatttttet‘ tttttl l't'eq1te:t('y nI' 2l(.l—
`Wllill detertnitter-t the tlterapettlit‘ (lose old thug 2'£l't(l
`ministratintt, as‘. well as the evettts‘. expet'iet'1eet.i {)\’t;'.!' time by [)1\[lt'l].l_*§t‘.-II taking the t‘t-et>m-
`l‘l‘I(El'l[lt.E(l (.lt>s:tgt: regitttett:-1. (:un:»'titttIe.s the both.-' nfthis hunk. It aims to tlenmttstrztte that
`there are t1ot1t'e]')t.~;emttttmtt to all tl1‘1tgs and that, equippt.-ti with these t'nt1t‘epts. not null)!
`cm: litany of the nthetwise ('nt1[it.~;in;_=_' events liuiluwing rirttg :l(l|lliI1l.‘iIl'}1llt>H he t':1tim1nl-
`ized, httt ethao the key qtttrrttitattt-t sut‘rnttt1tlittg' the \'CI'}’
`ltztsis of tln.~;;tg't'
`t'eg‘ittte.t1.~' mu he
`llI1(lC]'.‘iLf)0(l. The intetttleri result is 21 hetter and snlet‘ use 0]" (ltttgs [hr the treattmettt U1‘
`:lI1l(i'll()l'£11it)ll
`t>[‘tlise.;1ses tn‘ etmtlititms .~;tt|l'et'etl hy pzttietttet.
`l’;e:tt' in mind, for example,
`that still tntltty, SOIII-1‘ :"t"n 0|Wp21tie.ttts attlmittetl illlt}l1().*ipllEll are there het';mst-- of the inap-
`p]'()P]‘i}11(f use 0I'(lt‘ttg:-2. tntltth 0| whirh is 2l\-'t>l(iE1l}it‘.
`
`Thisrnaterialwascupied
`at the NLM and may he
`5ub'et:t U5 Co
`Fli'|i.l.i\'\r5
`
`Page 3
`
`

`
`n SECTIUNl
`
`I Basic Considerations
`
`FIGURE 1-1. An empirical approach to the design of a
`dosage regimen. The effects, both desired and adverse, are
`monitored after the administration of a dosage regimen of a
`drug and used to further refine and optimize the regimen
`through feedback {dashedline}.
`
`is pt:s.~ai|)le, &1I1(i itttleetlilu':t~i;1t'tm1mrm }):1.~'I pt':teIit'e. in {'.‘«'lElilii.‘-«'11 |i'i(’[1(J.*iil§_{t‘I'(':_:'i-
`It
`men nftt (lt‘ti_<_;' l|tmti;_=,'lt trial atnrl error i)j.' :t(ljttsIit1_g'
`.~<t1('}t
`f':tt't<3r.-; as the (i(J.‘«‘(' :tn(l iutet'\':1|
`i)(‘l\\‘L'{.'H rlmses nntl rt};-sen-'itt_'-.;' Ilte t'l'let‘t.x' ]Jl't}(iI1{'('(1 as tiepietetl in l"i;_=,'.
`I—l,
`.-\ t'e:1.~i<m;t|)le
`regitnett I‘Ili§_{i1l('\’(‘llHlEl”}'i)(-(-*-i{11i}iiSi1('(ii)1lI nut Wltiltlltl<(JIi1{'|)£lli('IH‘< e.\‘perien(‘itt§_{ ex-
`('(_“i.‘i1\"I‘.’ :tcl\'e1'se efl'et'Is LIIHI ()li'l('1'.'i ii1ef‘l‘et'ti\'e tltei';ip}'. (i('I‘I:li1li_\'. this wm the pm(‘etltt|'e
`I't>|lmx'etl to est;tI)lislt
`that tliguxin neetletl In he giver: :1!
`tlu.~'e.~+ i1(’E\\'('(‘I]
`I'll...-"J mg and
`0.2:") 1tt;_>_'tm|}'tmee :1 (lay it)!‘ |i1{' treutntenl uf' t‘t>i1_u;e»'ti\'e t':u'(|i:u'
`l:1iltu'e. \\'heI'e:t~i mot‘-
`pltittesttlfitte iteetlerl to lit‘iI(in1iIlifil('l'('(i :1I
`tlu.-;e~< lit-tween ll] ittgiitttl :'3l}1n_t_{ttp I'0l'rtitne.~'
`21 clay In :uleqtt'.1Iel_\-‘ relieve the t'ln't>|tit.' h'I‘.'\'{'|'(' pain exlat--rit-m'etl by |);l|i(‘]i1\' stIl'f'eI'ing.;'
`lmm I-:‘I'IlllI12li t‘;mt‘eI'. llm\'e\'et‘. Ii1iH{'lI1})il'i{';tl :tppmnr'lt nu! r>i1|}'l':til.~it<> e_\'pl'.Iin the rea-
`son liar this rlil'l'e1‘enee in the !'t’}_{illl(.'.1l.‘~'l)I'(ilg't)!(iI1éIlIfi Il1tJ1']Jil1Il(‘i)LIl:llH(Jt'(>IIll‘1i)l1I(’Sii1-
`tle. il';1n}-'tI'ting, t<m';u'(l e-'t:t|JIi.s|tin§_{ the ]}I‘1H{‘1[)i('"i
`t1n(lerl_\'ing_{ el'let'ti\'e (1{}‘-{2Ig'("
`rt-_9_'irnen.~4
`ta[‘c1t}t<-t'cii‘tigs. 'l'l1:tt is,r:tti'l>;1.~:ietmtlei'sI:ttt(1i1tg;'ul'rla'ng~<lmsrmt In-en iIl{'!‘(‘}l.‘~;('-ii.
`
`l'NPUT—RESPONSE PHASES
`
`i’I'r>g‘t‘<-.-s.~i 11:15 mil}-' i}(.‘('H fhr'tht‘titni:tg_{ by re:tli7.i1ig' Iltztt L‘mt(‘eItt:';IIimt.s :1! 2i(‘Il\'(" sites. I‘ii||It‘l'
`than rinse :1(lmii1i.~'tet'etl. tl1‘i\'t- t'e~e|mt1.se.s'.:1zttI that t<12It'ltie\'e;tm| nt;tinl:tin '.1I‘espnII.~tt'..
`it
`is l1(‘{‘('.‘s'.*i.':II'_\' to ('I1.‘i1|I'(' the ;_=;t':1et'::Iimt ml" the ;1p]J|'up1'i:tIe e_\'pt>-+ttI‘e-titne prralile nl‘ £1111.‘-‘C
`Wilhitl the imd}-'.
`'l\‘iIl('il
`in turn 1'eqttiI't.-N :tIt tI|1r|t't'st;ttttli:t;_>;ultlte l'nettai'-4 et>i1Im|liII_t.{ this
`('.\‘])I‘J.‘ilII‘(‘|)I‘tJI1i{‘.'I-]!(TS{"i(i(‘£l!-41111"HlIlI]IIl1ll'1Z(‘(i1!I 1-"i_<_{. 1-2. where tum‘ the illplll-l'(‘!-iptliieit‘
`I‘(‘i}1{itlI‘l.‘£]}1|)(\\’ill('il(J1'l('I1i'1ll15llll(i(‘1‘Iilt‘I'L"4lI‘l('li\‘('IiIit‘ “rlrase—i‘t'spt>iis(~.“as HUI only rinse
`is ‘.1ltei't-(1)
`is (Iivitletl inln IWO p;11‘I.s'.
`:1 pharmacokinetic phase anti :1 phzmltacodynalrlic
`plmse hull! with rraots (i('l‘i\'('(i limit the (ire:-l< tmrrl If)J"h|’.|'.i'l'.*rl(."r‘I’:.l.l. Ill('2lHii1;{ :1 (lrttg, or inter-
`e.~stittgl}'.
`:1 poismt. The pl::tmt:tt'nkit1eti(‘ |}il}l.*§L'
`('<l\'(‘I'.‘i
`lite t't.'l:1tim1.slIi|)
`i)(‘[\\’(‘{‘l1 (i|'1I}_‘{
`iI1})l1I.\\'iI1('il(‘{}I‘H})I'iS{'S HIl(‘iIEltiillrillihit‘i'§l(‘ItJl'S&1*l(if)S-‘.‘.(i()52I§3,'('ii.’}I‘III.11't‘(]l1{'I1I;'}';lil(1I't)IIl(‘
`t1|‘:t(lmiI1istI‘:tIitm.and the (‘(Ji]t“('1'lll'21l1()lI :tt'l'tie\'e(l ruff)’: rim». Tilt‘ pl1:u‘m;1t‘t><|}'t::tn:i(‘ pltatse
`
`Pharmacokinetics
`
`Pharmacodynamics
`
`A rational approach to
`FIGURE 1-2.
`the design of a dosage regimen. The
`pharmacokinetics and pharmacody-
`namics of the drug are first defined.
`Then, responses to the drug, coupled
`with phartnacolcirtetic information, are
`used as a feedback {dashed lines} to
`modify the dosage regimen to achieve
`optimal therapy. For some drugs, active
`metabolites formed in the body may
`also need to be taken into account.
`—
`
`Dosage
`Regime"
`
`E
`::Jpg::ge
`within
`Body
`
`--.
`Thisrnaterialwascopied
`at the NLM and may be
`Sub‘-ECTUS Co riht Laws
`
`.-o
`
`Page 4
`
`

`
`CHAPTER1 I Therapeutic Relevance E
`
`cm-‘t.-rs tht: 1't'i‘.tti(msitip i)t'l\\"t‘('I1 (‘r>11r‘t~1ttI‘:1timt Elllfi hnth the titrsi1't-ti anti 21(i\'(‘t'>i(' vi'l'{‘t'ts
`protittttctl trrrfli.
`tfi-rm’. ht sitttpirc tc1'Itt.s, plmnn:tc0kineliI:s In:t\_-‘ hr \-'it‘\\'t‘ti us imw the both-'
`i'I:l]!(iit;'.S the (i1'u;;', and pharmacodynamics :15 imw the time" ;1i'['t'u:‘ts the body. Scum.-tiim-.s.
`the 11tct21|m1itt'.~' ui'(it‘tI§_{s iin'mttr.i within the i:-ml}-' h;t\-'t‘ ;t-:'ti\'it}-' Llttti also mtt-ti in he t:1kt‘n
`into El(‘.(‘.L)liIl1 when rciatting (irttg :tth11inistr2tIimt to l‘{‘H|)(‘.-Ii!-EC.
`S(3\‘v.1‘;1l r)ti1cri):1.~;i(' irit-as ii:-Wt‘ i]t'.i])(‘(i it!]Jiitt‘('(i1'1l§_{iltiitliliif-illlliitlll rm :1 mutt‘ |'z1ti<m;ti
`i'imtin§_;'. Tilt‘ lirst, anti p;11'ti;tii}-'atiiutlt-cl to ;1i>:.>\-1', is that the i|1tt'|1sityn:'iii~;ciihtmri<>i't*i'l't-ct
`ii){‘I'{-‘Elf-itffi with iIlC1‘t':1Si!1g (‘X|J().‘il1I‘l‘i()1i1{‘ {i1'll_q', hut UIli)'lt}*+{)lIIt'iilllilitig,t)l'Iii2iXi.m1l111
`\"ziil1(.‘. ;ti)rwc. which the I'('Sp{ll1.H't_' cant go no ltigitcr, t‘t*§_{:1I'rlit'.ss n['|1t>\\-' high the cr.\'pn.sltI't--.
`St.-ttmtri, (i1‘11g.s act rm (lil'ii'|‘<:nt parts til" the hmiy, and the Itmxitntmt L--l'ii‘ct ])l't}(ilt(‘{‘{i by
`(III-1‘ rirttg nmyi)c\=(*1}+riii'|et't'1t1 iirmn that ni';mntiu':'. ('\'I;'.I‘1 ti1<1t1;_{h the Il]t‘:1!x'tlI'('.(i1‘t’S})(JII>i(2
`is the .~;;1mc. Fm‘ c:<:m1pit-.. lmth t1.~spi1'in and n'm1'phint'
`l'L'iitF\'(‘ pain, hut \\'|ttt1‘tr;1saspirin
`1m1_y1'ciit'\-'t' miitl pain, ii.t‘:lll11.(!l i‘L?ii(?\-"(‘ the .~rt:\-'r:1't.- pain t-xpc1'it'11t‘t-cl by putit-nts with H(’.\"(‘l'(’.
`l1‘L1tIll1':1 or ttatturr‘ ex-‘mt
`\\-'il(‘I] g'i\'(‘n in lI‘|'.t.‘-iHi\’t? rinses. ii('I't‘, i110t‘])iliIlt', U1‘ ‘.umt|urt' npirriri
`;1Imigttsi(', is the rl1‘1tg of citt;-ice. 'l‘hirtl, whirit iiriluws in part iimn the st-crrttti i(i(';l, is the
`l‘t‘E1ii'!El1i(>li that (iI'lIf.{'H |)I'(lt_ill('{‘ 21 11tt|it'iplirtiIy oi‘ tri'i't:t'ts. scrim‘ riesirt-.r.i and utltmzs l1I1{i.(‘.-
`sirtrtl, whiclt when t'Ul1|)it:'(i with the iirst idea, h:t.~a the ihilmt-1113.-1' implimlimt. T00 imv zut
`<'xpnst1t‘t' 1'trsttit's in an imttlt-qtt:1ttr [i(?SiI‘(‘t’i 1't-spmisr--. witt'I'c:t.~; too high :11}
`t;-x])ust|1‘t-
`in-
`(I1'{?Elh'('?S the iikciiimmi and intensit'\_-' oi" }l(i\'t‘t‘$it‘. ('.iit?t'lS.
`l'}x})1't&sst'tl riil'i'c1't‘i1tiy, tht'I'c exists
`an nptimzil |‘et1ig'(' oi" t-xpn.s1Irc.s i){‘l\\"t.‘('|1 these (‘XT.l'("1I1t‘h‘. the therapeutic window, simwn
`.~;L:heI1t;1ti(".1li}-' in I*‘ig. I-3. Fm‘ St}111t‘ clrttgs, the ii1t‘l‘}l])I;'.1lli(‘\\"il1IZi{J\—\' is I1;1I‘l'{)\\’. an-:1 lil(11‘[ri(Jl'(‘
`the 1n;tr§_{iI1 ui's21['t‘ty is small. For nth:-r.-4,
`it
`is \\-'i(i('..
`.-\itl1<J1t;_=_'h the 2'.]J])l'(JpI‘i&1l'.(' r:<:tt(‘.mttt".t—
`li(J]‘I slmuiri he that at the site 01' E1{'ii(Z-1']. rm‘:-It-' it is 21t't:t~.«_sii)|tr; ittstczui, the ('m1ttt'i1t|'attimt is
`gtttttmtii}-' rm-".1.s1|rcri 211 an Eli.it."l‘1'I}lii\'{‘ Elliti Ill()l‘{? ;tt:rtt-5.sii)lt- site. thv plztsmn.
`r"\l‘1t1t.'(i with titestr sinrpie i(lt';ts, it
`is now pr,~ssii)|t- tn t-xpiuin the rmsmt for the (iil'ilti‘—
`{?li('(? in the tinsiitg |'1't'qtit'n('y in"--I\\-‘ct-.|1 (iigrsxin zmti mm'pl:inc. Bnth (i1'1tg'sl1:1\'<".t H-:I21ti\'('|}'
`
`FIGURE 1-3. At higher concentra-
`tions or higher rates of administration
`on chronic dosing, the probability of
`achieving a therapeutic response in-
`creases {from gray to white}, but so
`does the probability of adverse ef~
`tects {toward increasing redness}. A
`window of opportunity, called the
`"therapeutic window,“ exists, how-
`ever, within which the therapeutic re-
`sponse can be attained without an
`undue incidence of adverse effects.
`
`Page 5
`
`Therapeutic Window
`
`9:I
`U)
`-:-<
`Lu
`:5:
`:E
`D
`
`DC
`
`Theraheutic
`Response
`
`Page 5
`
`

`
`n SECTIONI I Basic Considerations
`
`FIGURE 1-4. When a drug is given in a
`fixed dose and at fixed time intervals ide-
`noted by the arrows},
`it accumulates
`within the body until a plateau is reached.
`With regimen A, therapeutic success is
`achieved aithcugh not
`initially. With
`regimen B, the therapeutic objective is
`achieved more quickly. but the drug ccn—
`centration is ultimately too high, resulting
`in excessive adverse effects.
`
`
`
`PlasmaDrugConcentration
`
`Outcome:
`
`Excessive
`Adverse
`Effects
`
`Therapeutic
`Window
`
`lfleffeciive
`Th‘-‘=TaPV
`
`Regimen B
`
`Regimen A
`
`Time
`
`i'tai'1't:w |i]t.'1'i1})I;?11Ii{' witttlnw, hut \-vht'.rtras IIt()l'})i1lIl(? is t.-liIni11at.t:t.i very rapidly Iitmt ll1(‘
`lmtl}-'_. so that it must l)(’ 3.-,'i\-'t-n Ii‘:-qtit.-nil}-' tn ntaintain an E1(l(!t‘.1tlEl!(‘t'tJI1(‘t:t]lt'i1ll()]1 to t'.nstt1‘tr
`rtrlit-l" of pain without (.‘X(.‘t'.‘S_H'i\'t’ 1«'L(l\-’('1'S(’.
`t-.l'l't?t‘ts, stitth as rt-.spii';tItn'y titrprtrssitm, tiigtaxin is
`i‘t.-lati\-’t--.l}-' sI.;thlt- anti so with iiltlt‘ lust t-ach (lay, t’JItt‘t'
`tlail}-‘ atlniitiistralitan sttliitx--.s. 'l‘lics(-_
`pi'int‘iplcs also help to explain an :l(l(lt‘(l lt‘;11tn‘t.- t)l‘tiig>;m<iti. ('}i\-'tén daily, tligtntiii was t-rithtrr
`int-t'i't.-tztit-‘tr d(‘tI1t_Ti)’ or trvttntttally |)t‘t>(ll1(2(ftl ltIlil('(‘t'|Jl;li)lt.? toxicity when a tltising‘ rate sI.tl'ii-
`t‘it.-ittly high to l'JL.' L.-l'i't-t'ti\'tr acttltrly was inaiittaint-.-ti. B(?C21lI3-it‘ it is trlitttinatctl slowly with lit-
`tle lust
`(.'1I('lt
`(lay.
`it attttiitttlattrs a|JpI'ttt:ial)l}-' with I‘t_'[)CE1I("(l
`tiaily atltninistratitnt. as
`tlt1pit'It.-tl H(‘.l}t‘I1I2lli(.iilll)-' in l"ig.
`I--'1. At low daily tinst.-s, the initial (I(Jl'1(‘(‘.Illt‘Elll(J]1 is tun low to
`ht? ttf'['ct‘Iivt_- hut t?\*'t.?lI|lIEl]l)-', it rises In within thtr tht-.-i'apt't1I_it' wintltiw. Int'1't.':tsing tilt.‘ daily
`tlr>st;.- lirings Illt‘ t:m1t'c11traIitm witltin thtr thc1'aptr1ttit' wintltaw t.‘1tl'ii(.'I‘, hut with lllt‘ (‘.t)I]('{‘Il—
`n‘2ttit:n stiil
`I‘isii1g.
`t'vt.-Iitttally thtr t_‘.tntt‘.t:nt1‘atitm htrtttnntts [00 l'1ig‘lt, anti tt]l2'i(IC(?I)i:ll)l(‘
`l().*(i(‘it}' t-nsutrs.
`lltiwt.-\-'t-r. what was l1(.'t'.(i(‘(l was rapid E1(‘.i‘li(?\-'{?Iltt'I‘t[ anti Slll).'-ltZ([1lt.?t'Il main-
`tvltantttr t>l'
`'¢1{l{:f(]lIE1I(‘ tligtixiit (‘(}vI](‘{.‘.l’ttl“¢t[i(ll't_‘-L Willi-{Jill tlntlttc atlvtr1‘str t-vllcttts. Tht: atiswtu‘
`was In t_>_'ivt.-
`.\'('.\-'t‘I‘ili sniall t|tist:s within the Iirsl (lay, t‘.tnmntit'1Iy known rtilltttttivtrly as at (digi-
`rttiiziiig rfmr’, In I':1])l{li)-'E1(‘l1i(‘\'{‘ t|1tt1'a].)trt:t.it' t‘tmt't-.i1ti'aIitms ltwilnwt-ti liy small tlaily tltistrs to
`maintain lll(‘ t'(>Il(‘{'Iill‘&1|l():I't within tht: llI(‘I'Elp(.'.llli('Wll1(ltJw.'I.l1(?lL!.*§S0lI to ht-r i{‘}1l‘I’t{:'(l l'm1n
`lllt’ t'ast- 0l'tlig'tixin anti intltrtrtl inns! tlrttgs is that nnly tl1t‘tntglI an Illicit-rI‘staritli:1gt>l'Iht-
`tmnpmal t-\-'t-nts that ()(‘.(‘.llI' ztlit-r the tli'ug's tttliiiiiiistratitm can i11caititig'l'ttl tltrcisitans he
`math‘ i't-g'at'tli1ig its nplinial nstn
`'[‘ht* iss1tt‘t)l'timt.- tlttlays htttwtrt-.i1 (ling atltttitiistralititt anti Itésptittst-. is |1{Jl tttinlint-.(l to
`i)il£lI'Ill£I(‘tJkill-1’il('S hut t-xttrntls to plIamtactitlyitittttitis Int). Part tJl'sut:l1 tlttlays is a :'t'stIlI til"
`Ihv Iimr rt.-qttirtrtl i'n1'tlI't1_t;' tutlistI‘il)tItt.' [t)iit{T IaI'gt:tsi1't%. whitth is ni'tt:n in a cell within a
`tissuetu'tn‘t{;tit,sIIt'l1ast|1tri)I'ain.'i'iiisis t‘t:rtainlytl1tt cast: with tligt)xi1i,wi1t--.i‘tr tht-r ptralt t:l"—
`l't-t:I tut thtr il{'.:l]‘|
`tJt'(‘1II's s(¥\'t?I‘£ll lmius altttr t)l)S{?IVltlg' the [wait t-txptastinr in plasina. Part is
`also a rtrsttll oi" (lt'lil}’S within lltt‘ afl't‘t'tt-ti systt-‘iii within the htitly, as I'(?2t(lil)’ sot-it with the
`urai &tilllt“t‘)}1§3;lli£lTll t\-'ari'arin. ll.‘i(?{i as a pi‘tap|ivl2Ixis in the pI'L‘V(?Illl()I'| t)t"rlt-cp vein thmini:ta—
`sis and nth:-I‘ tIimi'nl)nt'Inhnlit‘ t‘tmi]Jlit‘atitms.
`l".vt*.n Ihtntglt the (lt't1gis 1'apit.llyztllstirlitttl,
`)'i('i(iiI]t{llig‘]1,(?2l1'l}'('()l]t'(‘IlII'£1Ilt‘}it!-tIltrtillglltlill lilt‘ l‘JU(i}-'. as seen in Fig. [-5,t.litrpt:a1k t=.i'l't-tit,
`in It.-rms t.~l' p1‘t>lt)11;_§atitm tJi_Il1{‘ clotting tinttr, nt‘t'.ttrs appttixiittaltéiy 2 (lays afttrr 21 (Inst: of‘
`\\-'at'l'aI‘iI1. (llt-;tI'ly.
`it
`is iinptirtaltt In I:1I<t' this lag in It-.sptntstt into El{'.(‘{)lllll wht.-n (it-rttitliitg
`how IntIt'h In tttljttst tl()St‘ In at‘hit‘\-‘t‘ anti mailttaiit a g'i\'t-.i1 tl1ct‘apctttic rttsptittstt. Failing in
`do so and :tIt<_tnipti1t;_>_' to atljtist (l()_*i£I}_’_'(’ |iast'(l, liar t-,\':11nplt%, on il't{'? I‘{-?S])()l'|!-it‘ S-I‘{"l1 al'ttn'
`] titty,
`i)t.‘itJI‘(’ the hill t.-l'f't'.t.'I tit-t-'t'|t>ps, llt(‘l't'2t.‘s'{‘s tht: tl:t1I_t;‘t'i‘ til't>\!tri‘ti<:siIIg the patient, with _st-rritatis
`])()i(‘Illi2i.l ('(J]l.‘it'q1l{FIiI.’.‘t'.‘i. s1It'li as inlttrnal lttrII1m'1'l1agt‘, with this low Itt;tt‘;_§itt-tillsttltrty th'ttg'.
`Page 6
`
`Page 6
`
`

`
`_L I\3
`
`
`
`PlasmaWarfarrn
`
`
`
`Concentration(mgfL)
`
`CHAPTER I
`
`I Therapeutic Relevance n
`100
`
`W(3
`
`
`NI-lbO}DOD Percent
`
`DecreaseinNormalProthrombin
`
`Activity
`
`2 D
`
`ays
`
`FIGURE 1-5. The sluggish response in the plasma prothroinbin complex activity {colored line}.
`which determines the degree of coagulability of blood, is clearly evident following administration of
`the oral anticoagulant warfarin. Although the absorption of this drug into the body is rapid, with a
`peak concentration seen within the first few hours, for the first 2 days after giving a single oral
`1.5 mgikg dose of sodium wartarin, response {defined as the percent decrease in the normal complex
`activity} steadily increases reaching a peak after 2 days. Thereafter, the response declines slowly as
`absorbed drug is eliminated from the body. The data points are the averages of five male volunteers.
`iFr0m: Nagashirna R. U’Rei|ly RA, Levy 6. Kinetics of pharmacologic effects in man: The anticoagu-
`lant action of warfarin. Clin Pharmacol Ther l969;10:22—35.l
`e_.
`
`Am.Jtl1c1' ttxalttpltr of El timrc (It;-.I21y in plizu'z1iz1t‘0(Iyti;tiiiitts <:t>nt‘trnts an ettlx-'t.-rsc cfll-.(‘t, £1
`snlttty issue, .‘itf(?l1 in Fig. 1-0 tiller :1 siiigle iiitmvcitititis (lose 01' th:-.
`'.mtit".tnct't‘ (hug incli-
`tatxt-el. A (.‘.{}tI1tt‘t(.JJt and ciinittztlly sigitilittzttit l{)Xit'i1}" oi" l‘I1i1]l}’ 2llI1iC:l]]('[?I‘ tlrttgs is lct1kt1|1c—
`Mid, 1111 ;il)n01‘tt1;tl fill] in tht-. 1ttttt1i)t‘t't)f|t:ttk0t:yltrs in i)]{)t)(i. l.t‘t1knt‘}-'tcs are in1pm‘t;1nt. in
`li‘t(‘ iI]'llIllll10i(Jgi{‘}li (.lt:ic1tst‘ oi‘ the body and ii‘ the lt'i:k(it:ytt- cminls I11]! I00 flu‘,
`il plarit-s
`the pal'it:11t at st:vt:rt: risk. Most (iiiltiflli i'm:us tlitti'cl'm‘c is on the lowest lt-ttkut:yt.t- t‘.m.tnt
`ni't.(-tr C]](:T1]](Jli1{‘?l“¢‘t}}y t'rc:1ttt1tr11l., httl the time cnttt'st* til" the iitll
`in ('.t)ltttl and rt-.ttu'n to
`hasclitttr is also i1ll])(‘J]‘l}l]1l.
`lltzspitc |):l(‘]il1lx('i
`|)eii1g_v_‘ eli:11iI1'.1tvtl
`l":'mt1 the hotly within
`
`
`
`SurvivingFraction
`
`0
`
`100
`
`300
`200
`Hours
`
`400
`
`500
`
`FIGURE 1-6. The fraction of leukocytes in blood [relative to baseline} with time in a patient receiv-
`ing a single intravenous dose of paciitaxel. Notice the sluggish return of the leukocyte count to the
`baseline value. The continuous line is the best line fit of a model of the production and destruction of
`leukocytes to the data, with paclitaxel inhibiting mature cell production. (From: Nlinaini H, Sasaki Y,
`Saijo N. et al. |ndirect—response model for the time course of leukopenia with anticancer drugs. Clin
`Pharmacol Ther 1998;64:5ll~52t.l
`
`This rrlateriaiwas copied
`
`Page 7
`
`Page 7
`
`

`
`u SECTION] I Basic Considerations
`
`l(ElIl(tJt?)"l(¥H in l)lt)t)(l is L'xll't‘]]l('l_\' slltggislt, tttkiiig
`2 (lE1)".‘i. lllt‘ <'lt;ttigct~' in the lrttctititi n|'
`()\-’('I' G \$-'L't_‘l»’. tn l'{.'ElI‘.'lI
`lllt‘ l<)wc.st ['<)UI1l and mil}-' rctu1't1i1I;.{ to the lJEl.‘-3["lil1L' V;-tlttc 3 W('.t'l<..*i
`illlcl‘(ling;1(lmini.~;I1'z1Iitm.
`l.ctIknc_\-'tcss in blood 1‘t:ilL-(‘I thv l):ll£l]1(‘.(‘ l)(.'l\\'(‘t'l] |)!'(){lllClll}Il
`tutti{It-strtttrtimi.'l"l1t-tlirt-('I inhibitor}-'trllkrtrt<)l'|J:1clit2tx(>li5ttpst'r<*:1IIim1 |)I'fJ§_{t‘I1ilt'.lI'tii{.fllS
`within the l)(JI!{.' trittrmw tlu.-i'cI)j.'
`rt-(ltt<‘.i|ig_»_' thu pl‘tJLlll('l.l-f'JI'1 til‘ ]'I}&llll1‘(’
`|t'ttk(:(‘yltr.~;.
`l*"c\«-'61‘
`lIIE1l1lI'(‘
`It-ttk0t‘_\'tu_~e I'<~.-ml into llit‘ V-'11St'1ll21I' pool so that ll1(F}')(){_)l3-3lZ{‘(lt?Clll1('H. hut a lung
`tint-1' i_~;iicv(lt-.-tl to [)]‘t)(l1l(‘t‘ 21stIl'ii('it'nt l1i.l]]Il)(‘I‘ t.~l'nI;tI.Ii1‘c lt'tIkt:-rylt--5 to ugttiit t'mIt>1‘v the
`ilt‘.-]'I]12ll hlnml ]Jt}{Jl.
`tl1t:_v Cxliihil (lil'itri‘trI1l cl-
`As I1l('l]1it’)IlL‘(l. an ia1I<ri‘(rsti1'1gl'k‘;1I.iIr(?<al'I11;1t1y(lt'tt§_;'sistlmt
`limqts with plttsiiitt C{J[1tI(?IIlI‘1I[l()lI. An ttiittslutl hut tclliltgt-xt1nIpl{* is St.'(-Ell with clniiiclinc.
`()1‘ig_=,'imi|l},- (lt.‘\'L‘ln]Ju‘.?{l as ;t
`I1£l5}\l tltrtttaltgtrstitiit. Wllt-Fl!
`t.'\.-'i1lII:1|t?(l [hr this iI‘i(ll(':lIl{lII.
`.~amm~
`s'tIl)_jcct.s' l)L.-(';11m' Iitint, l){.'('}lllH(?t)l'1l then ti1i(r.\’ptr(‘tt-‘(I lI}’l)(Jl{‘IlHl\’(‘ t.-ll":-.rt. 'I‘u(lz1y, the ther-
`:tp(-.-utic user 01' this tiring is H5‘ an tuttiltyp{'I‘teIisi\-*t‘.
`l'lt)W(‘\’{'l', f'tu'IlIci'
`lII\"{3Sl.ij_{21[it>II sltnwul
`that
`it wuss pm.-s.~'il)lc
`to [)I't){lllI‘..'t.‘ not only it
`|I_v|J(JIt*I1si\-'0 ttllctit
`l)lll also ll)-'])(.‘l‘It'I].*il{Jl].
`tlcptsntliiig on llltt plzvalmt cmt(.'t.-nlrtltitnt. (Iltmitlimt acts on two ('lilH.'il;.'.\i ul‘1't‘(‘tr])tm'. one
`t‘;u1.~:ii'tg‘:t lnwt.-riltg<>|'I)|t)0(l [)I'{.'hi_‘a'l1I'(‘ and the t)[l‘1t.'I‘ tut t.?l(‘\’Elll{Jll in Iilnml pI‘{-'.*iHll!‘L'. At low
`(‘()]It"L2l}II'Elll()lI.‘i 2l(.‘l'll('.\"(.‘lIl with IlIt?l'2l]J(TlIl'l(.‘ tlustrx,
`I'll-i.’ lowering c['['t'(‘t on l)lt)(){l p1'csas1ti't‘
`|JI't.'(lU]‘|1lll:lI()S. but at ltigh (.‘()I1(‘.(3IIll‘1l|ltnlfi,1lSIlIlg'l1[W('ll hr: zttrliit.-vutl (lltring't11i 0v(r1‘tlu.~st.'.
`the li}’pt:I‘tctisi\-'L: ellcct ]JI'I‘.P(lt)IIIl]Hll(.'.S, ztltlmtiglt this L-['l'c('t will .‘illl).*il(l{' and the ltypt}tcn—
`-‘Sh-’-1‘ t‘l'li%ttt will ttgttiit lilrtlcailiiitattt: as the systcttiit‘ (_TX}){}.‘§lll'C litlls. Fm‘ .‘1'()}l]|'.' olltcr cl:‘IIg.*a,
`sucli as W'21l'l}tl'lI‘I, the tmrtilizlllisiit oi" Eltilltlll is thv 9-ielllltf I'm" pmrlttttiiig‘ (lt..':~ill‘t:(l and '.1<.l\-'<.-|'_s'c
`t:l'l1'r_:I.s'. WztI'[':lt'it'1'.~' illlilflfit sitigttlztl‘ ;1(‘tim'1 is inttitrnngttltttimi, )»'r:1
`thi.~s c-rI'i'c(:t
`is tlvfinctl as
`IllI;.'I‘11]Jl..'llll(‘Wlltfll Il1{)(?()ll(i(FI'Ill'Elll{)!‘] is .~;iI(‘li as to llllllillli‘/_t‘ the risk nl‘<lc\'L:l<>pim:1it ol';m
`(’II1llt}liR]‘J'I and as 1l(l\-'(-'I‘.‘it' at ltighcr c0I'1t'(-:ntrzuiuits at which thv risk til‘ ll'Il["i'll2ll
`l]('I‘I‘1()[‘—
`rltztgo l;-r..-(mitt.-.~s high,
`‘cl:-4.‘it.)(‘.lEl|{;.'(l with excc-essivc ‘.1111l(?0Zlj_‘{lll&1[l()l1.
`'l‘]u--
`l('ES.‘i{llI
`is (‘l(_-:11‘,
`l_.l]'l(lt‘.I'_*iI2Hl(llllg Il]t.' .~sp{'t'iiic cmnrt.-i11mtit'm—t't::sp0i1st- time I‘t'l}lllUIISlll]J.*i ltclps in the man-
`ttgt-trlcitt and captimul tum: n|”{lt'ttg.~;_
`
`VARIABHJ TY IN DRUG RESPONSE
`
`Ilwtr Wt'i‘{F all alike, tlicrv wuultl only l)-': mu: (lost? stmitgtli ancl 1't;'.g‘itt1v1i Ulél(ll'l1gI]t.'(P(l(:(l
`I'm‘ the {'llIiI‘{.' pntit-mt [)lJ[)ul‘.t.[lt)]l. But w F art‘ not ztlikc: iI1(.lt:(:tl, we often t.?.\’lIll)ll g_=;1'c:It in-
`t(:t'imli\-'i(ltt;il
`'2lI'i2tl}llll}-' in r<:spun.s'(r In Llrttgs. This is gt-tit-1':-ill)-' not so importtmt fut’ (lt'1tg‘s
`with \\-'l(l(’ Il]I‘..'I‘}l]Jt2HIi(‘ witttlows, l}(‘{‘.ill.l.‘il.‘ pnlicitts (inn [tJl(:l‘Ell.{T 21 \\-'l(lt.‘ raulgv t1l‘('x]')t>stI1‘c.~»'
`li.'.>rsi111il:tt'(ltrgi'(rt'snl‘|)t't'1L'lit.,]'):u'ti(rul211‘l)-'when thtr dose t-'tt1pl()yt'(l (.‘I3h'1ll‘(?.*i that tlw m;Ix~
`imilm lJ(‘ll(?li('ldl L-ilt-(‘I
`is trxpt.-|'ic.-n(‘c(l by trsstttltiztlly all pattitrllts, in whith tt‘;:.~.-ct El
`.~eit1glt=.
`(lnsv ol'cli't|g, Illt.‘ "cutc—(lnst-—lii:'-till" l(l(.'£i.
`.~;ui'li('tr.~:. i'\|tlm1tg|1 soiitv patit-ms inn)-‘ still not
`Ivspntttl In tltwttp}-' l)('(‘}lllSL' they l;1r_‘.l< the pttttllivc1't:t‘(*ptuI'0t1 Wlll(.'ll [l1{T(lI'Ilg'cl(‘|.‘i. :1 I‘1lI‘t?
`in(li\-'itluul I}l2l‘\_-' (r.\'pt'I‘it.-Ian‘ :1 ll}-‘pt.-i‘.~scii.~;itivil}-' t‘t:;tct'i<_m, sttclt as an acttt r }illt..'l"E_l"l{' t'|.)i:m(lc.
`(Ilv;n'|_\*. the (l1'tt;.>; is (‘UHlt':ll]l(li(EllL'(l in the last. two tylies til" patient. 'l‘ht- pmhlcnt nl'\-'zu'i—
`nhilil}-'
`l‘.-{'(‘tJII1{.'.‘4 1Jm‘Iit'ttl;1:'l}= 21{'l£I.(: I'm‘ (lt'tIg5 with an llIl{FI‘l‘t1{?(ll'rll{' or n:1I'I‘m.\-' {llt'l';1])(.’tlll{.‘
`\\'ilI(,lt>\\', nl'wlIit'|i !ll('l't'£1l‘(‘IlI}'tIl}-’, l11(‘ll1(llI]j_§ thc iII1nilIIlt)Sll[)p]‘()SSl\"{? ;tg'L'riI L‘)-'(‘lcJspt;I'iI1t',
`l1.\'t‘(l
`In })l'(‘\'{-‘Ill
`(Ji‘g‘;ti1 ngjtrtttinit
`l'tJl|0i\-'iiig_{ II‘21]I.*ipli1]‘I[Elliot], and the niititrpilcptic‘ drug,
`pl!(’II}"[()l]I (Fig. I-7), in 11(l(llllt)I] In the trxuinplcs til" inurphinc a11t(l(lig(:xiI1 rm-ntimn-(1
`|Ji'L-\'it)tIs'ly. Fm‘ [llt.'S('
`t|I‘ttg.~;, the stiltttimi is the 1l\"i1ll2.ll}illl.)' 01' tin ;11'i".ty (Jl rlcmr .~att't.-.ti;_=,'Ilis,
`with Iitrttlinn ul'v;t(‘l: I}dll(,’i]I tn the l‘Cql1iI'(.‘fl rlusttgtr.
`\-";t|'i;thiliI}-' in tht- |'{'Hl}i‘]11St.‘ ttrizciitg [')21ll('.[]l'.'-; In pltmiytoin and tnztng.-' ntlwr (l1'ttgs is pri-
`mtn'i|}-' ]Jli;1rn1;1t‘oki1i(tIic in tirigin. In <itl1c1't'.a.~;L-.5, pli;ti'tt121t:raLl}-'1mIItics is tht: lIIitj(Jl' c;11t.~;t-
`r1l'\'2t:'i;1l)ility in I'('.*i]Jt)Ii_*x'-1?. as shown, li1:‘L'..\';1Iii])lt.', in I’ig. 1-8 by the with.‘ nutgo in pl:1sm2I
`cr.~1tccntrzttimi.w nltltc oral éttitittciztgttlttttt \\-':lI‘l}lI‘iI1 l1{3t'::(l{‘(l to IllEllI‘tl.dlI1 :1silllil21I'(lL‘gl'{‘t?()l'
`EIll[l(‘()i1glll£IlitJl1 in p:1Iit'I1t.~.'.
`l‘('..*ip()ll.‘i(? are mtuliloltl and in(‘|u(lt: tho pz1titr11t'.~i tlgtr,
`'l'llt.- ('1tllS(‘:~i ul'\-'2li'i;1hiliIy in (l0.*;<'
`\\"(?lf_{l1l, (l('§_{I'{T[' til" t)l)('.‘ill}’,
`t,\_-‘pr zlllfl r|c;_;'1‘t't- oi":-it-.\-'cI‘ity ul'(li.~itrtt!sc, tJIll(?l‘(ll‘llg'S(1t)ll{?llI'|'{‘]lIl}v'
`;ttlIIIi1Ii.~tI(:1't.'tl.gtntl{'1t\-'imI1mcIIl;tl llt('tt:t's. .'-\n0Il1(?t' im]mt'I;uIt and p(:n';i_-;i\-'L- ¢JlIt'.'.‘ is }.;'{?1It:ti(‘.s'.
`This materialwascuied
`Page 8
`
`Page 8
`
`

`
`CHAPTER} I Therapeutic Relevance E
`
`average
`FIGURE 1-?. Although the
`plasma concentration of phenvtoin on
`chronic dosing tends to increase with
`the dosing rate, there is large variation in
`the individual values.
`lFrom: Lund, L.
`Effects of phenvtoin in patients with
`epilepsy in relation to its concentration
`in plasma. in Davies DS, Prichard BNC.
`eds. Biological Elfects
`of Drugs
`in
`Relation to Their Plasma Eioncentration.
`London and Basingstoke: Macmillan,
`1973:22?—238.i
`
`-h0
`
`
`
`PlasmaPhenytoin
`
`
`
`Concentration[mgi'L)
`
`5
`
`10
`
`Daily Dose (mglkg) an
`
`'l‘hi.s was known 1'01‘ mutt)-' yt*;trs_ in that W]I(‘ll t'\';1lu:tlt-(.1, IIICII‘ \\."{‘1'{‘ uni}-' tninm‘ tlif'l'k-:1‘t‘t1('cés
`in |i'I(‘. ]_)It:t1'Itt;1cnkiItctics and I‘cspmt.<sc to (iI't1;;‘.s i)t?l\\-’('(".ll
`i(i{‘]lli(‘.:li
`twins t-\-mt wltcn they
`|i\-'t-(1ztpat‘1';uul iudil'l'trI‘t:nt social t:u\-'iI'mtmt-nl.~‘.. cr.>|ttpm‘v(i with the when <-rxpt.-i'itrtt('c(l Wi(i(.'
`(lif'l'm't.-i1t:e.s in rt.-.~a|m:i.w within li1('. [)d1'it‘ltl [J()|)lli21li()I1. 'l‘|tt.- iIttpm'I:m¢‘c t>l'g‘mtt.-li('s \-vus also
`i(l'I()\\-‘ll limit liuttilinl .'-+l.11(ii{‘S and .‘-3llI{ii(‘S in tlilfi.-rvitt t-t|mit' 5_=,':'ut|ps. ()Il('. t.-xnutpltr, :-u'ir-;in§_{
`tl1tt‘i|tg Wm‘ltl War II, whiclt ()(I{‘.1ll'l‘(.'(i wht-.n lltc liglttittg H|}I‘t_‘2l(i to 1‘l‘U}}i{‘.E1i
`I‘c;_>_'it>m WiH.'I‘('
`m:1I;tI‘i;1 was riltr, wets the <>l)sct‘\':1tim1 t

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket